Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL
T-cell prolymphocytic leukemia (T-PLL) is a rare malignancy with a poor prognosis. Here, the authors investigate the genomic landscape, gene expression profiles and functional mechanisms in 111 patients, highlighting TCL1 overexpression and ATM aberrations as core lesions which co-operate to impair...
Guardado en:
Autores principales: | A. Schrader, G. Crispatzu, S. Oberbeck, P. Mayer, S. Pützer, J. von Jan, E. Vasyutina, K. Warner, N. Weit, N. Pflug, T. Braun, E. I. Andersson, B. Yadav, A. Riabinska, B. Maurer, M. S. Ventura Ferreira, F. Beier, J. Altmüller, M. Lanasa, C. D. Herling, T. Haferlach, S. Stilgenbauer, G. Hopfinger, M. Peifer, T. H. Brümmendorf, P. Nürnberg, K. S. J. Elenitoba-Johnson, S. Zha, M. Hallek, R. Moriggl, H. C. Reinhardt, M.-H. Stern, S. Mustjoki, S. Newrzela, P. Frommolt, M. Herling |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/27f303840c0c4d6e8ca4ef99b0371076 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The TCL1A oncoprotein interacts directly with the NF-kappaB inhibitor IkappaB.
por: Virginie Ropars, et al.
Publicado: (2009) -
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia
por: Gero Knittel, et al.
Publicado: (2017) -
Advanced Pathogenetic Concepts in T-Cell Prolymphocytic Leukemia and Their Translational Impact
por: Till Braun, et al.
Publicado: (2021) -
The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A
por: Johanna Stachelscheid, et al.
Publicado: (2021) -
Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies
por: Natali Pflug, et al.
Publicado: (2021)